Plasma levels of IL-17, VEGF, and adrenomedullin and S-cone dysfunction of the retina in children and adolescents without signs of retinopathy and with varied duration of diabetes.
about
Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on PhysiopathologyIL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling.Hypoxia-Inducible Factor-1α Target Genes Contribute to Retinal Neuroprotection.Blocking IL-17A Alleviates Diabetic Retinopathy in Rodents.Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss.Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus
P2860
Plasma levels of IL-17, VEGF, and adrenomedullin and S-cone dysfunction of the retina in children and adolescents without signs of retinopathy and with varied duration of diabetes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Plasma levels of IL-17, VEGF, ...... h varied duration of diabetes.
@en
Plasma levels of IL-17, VEGF, ...... h varied duration of diabetes.
@nl
type
label
Plasma levels of IL-17, VEGF, ...... h varied duration of diabetes.
@en
Plasma levels of IL-17, VEGF, ...... h varied duration of diabetes.
@nl
prefLabel
Plasma levels of IL-17, VEGF, ...... h varied duration of diabetes.
@en
Plasma levels of IL-17, VEGF, ...... h varied duration of diabetes.
@nl
P2093
P2860
P356
P1476
Plasma levels of IL-17, VEGF, ...... th varied duration of diabetes
@en
P2093
Artur Bossowski
Izabela Szczepaniak
Jerzy Wójtowicz
Kornel Semeran
Przemysław Pawłowski
Łukasz Lisowski
P2860
P304
P356
10.1155/2013/274726
P577
2013-11-18T00:00:00Z